Sign in

Dr Nicholas Brittain

@drnickbrittain.bsky.social
8 followers 11 following 1 posts

Postdoctoral Researcher studying paediatric leukaemia epigenomics in the LEGEND group at Newcastle University. Interested in transcriptional regulation, epigenomics, alternative splicing, CRISPR and bioinformatics.

PostsRepliesMedia
Reposted by Dr Nicholas Brittain
LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 02/10/2026
Last month, @letimarchetti.bsky.social gave an introduction to our research to the team at Leica Biosystems. It was a great opportunity to share our work, discuss our research, and exchange ideas. Thank you to Leica and @childcancernth.bsky.social for the invitation and the engaging discussions!
033
Reposted by Dr Nicholas Brittain
LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 24/09/2026
On #WorldCancerResearchDay, the group embraced #gold to support @childcancernth.bsky.social initiative #PaintTheToonGold to raise awareness for #ChildhoodCancerAwarenessMonth. Our efforts go beyond the lab when it comes to support #CancerResearch 🧬🧡
035
Reposted by Dr Nicholas Brittain
LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 18/09/2026
This Blood Cancer Awareness Month, we stand alongside patients, families, clinicians and researchers working towards a future where blood cancers are detected earlier, treated and ultimately prevented. Every discovery starts with research at the bench 🧪🩸 #BloodCancerAwarenessMonth
Thank you to Martin Newman for capturing our research in the lab.
044
Reposted by Dr Nicholas Brittain
LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 11/09/2026
We’re glad to have participated in the 23rd CLR-UK Annual Meeting in Nottingham! It was a great opportunity to share our research, contribute to organising the meeting, exchange ideas, and network with fellow scientists working in childhood leukaemia research. #CLRUK2026 #BCUK
033
Reposted by Dr Nicholas Brittain
LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 04/09/2026
A multicultural lab group comes with so many advantages! We don’t only share valuable ideas and different prospective, but we also get to share traditional food and learn about each other's cultures. ​ Thanks @alsayadi.bsky.social for introducing us to Arabic coffee and sharing sweet treats!​
Arabic coffee, dates and traditional sweet treats.​
055
Reposted by Dr Nicholas Brittain
LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 31/07/2026
This week @dr-ahlamq.bsky.social has been preparing DNA for long-read sequencing. Historically, DNA is broken into 'chunks' to read the code. Long-read sequencing is newer technology for deciphering much longer stretches of DNA, providing in-depth information about leukaemia genetics.​
Dr Ahlam Alqahtani is carefully examining a tube containing DNA that has been extracted for long-read sequencing technologies.The long strands of DNA 'wrap-around' glass beads within the tube, enabling us to extract much longer DNA strands than traditional methods.
053
Dr Nicholas Brittain @drnickbrittain.bsky.social · 27/07/2026
We really enjoyed hosting Lucy and Kunwoo. Two very talented students that I am sure will make a great impact wherever their careers take them next.
010
Reposted by Dr Nicholas Brittain
LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 04/06/2026
@letimarchetti.bsky.social represented the LEGEND group ​ at the 'Young Researchers Chromatin Club' seminar series by @activemotifusa.bsky.social Leti presented exciting research progress, using multiple chromatin profiling methods to understand genetic regulation in leukaemia.
A picture of Leti's online Young Researchers Chromatin Club seminar on Zoom, viewed by a laptop of a LEGEND group member.
052
Reposted by Dr Nicholas Brittain
LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 05/05/2026
🧬 Fighting Paediatric Leukaemia with Epigenetics: 4-Year PhD Opportunity!​ ​ Looking to push the boundaries of cancer research using cutting-edge epigenomic technology?​ ​ We are seeking a dedicated PhD student to join the LEGEND group.​ Full details in the link below:​ bit.ly/LEGEND_PhD
The LEGEND group in the lab.
From left to right: Dr Ahlam Alqahtani, Dr Nicholas Brittain, Dr Letizia Marchetti, Camille Drai, Dr Lisa Russell (group leader), Ahmed Alsayadi, Phoebe Snow
134
Reposted by Dr Nicholas Brittain
LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 30/03/2026
Last week was an exciting one for the LEGEND Group! We attended NUBI Live, where Lisa and Phoebe gave talks, and Ahmed and Leti presented posters. Nick also presented in the @nucancer.bsky.social PMGI Symposium. Excellent science with plenty of engaging discussions!
062
Reposted by Dr Nicholas Brittain
LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 21/03/2026
Very proud that LEGEND Group technician, Camille Drai, won two prestigious Techncian Awards. Well done @camilledrai.bsky.social 👏
072